Czechia – Pharmaceutical products – Lutecium-177 vipivotid tetraxetan [2025]
Masarykův onkologický ústav awarded Kč124M to Novartis s.r.o. for Healthcare & Medical in September 2025 — one of 349 awards this buyer has made, above its typical award size.
Buying agency
Masarykův onkologický ústavWinning supplier
Novartis s.r.o.Contract description
Czechia – Pharmaceutical products – Lutecium-177 vipivotid tetraxetan [2025]
Related awards · Masarykův onkologický ústav
349 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-359550-2026LERAM diagnostic s.r.o.Kč252M27 May 2026 Healthcare
- ocds-ted-255026-2025SYNEKTIK Czech Republic, s.r.o.Kč246M18 Apr 2025 Healthcare
- ocds-ted-479599-2026-2Bristol-Myers Squibb spol. s r.o.Kč150M10 Jul 2026 Healthcare
Other wins · Novartis s.r.o.
15 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-695488-2025Fakultní nemocnice v MotoleKč1.4B22 Oct 2025 Healthcare
- ocds-ted-351155-2025Nemocnice Na HomolceKč103M02 Jun 2025 Healthcare
- ocds-ted-205782-2025Všeobecná fakultní nemocnice v PrazeKč83.7M31 Mar 2025 Professional Services
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Masarykův onkologický ústav and Novartis s.r.o. — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back